drugset / Trial / NCT05149599
Saccharomyces Cerevisiae for Irritable Bowel Syndrome
NaSingle-groupOpen-labelTreatment
Summary
This study is designed to see the response of saccharomyces cerevisiae for symptomatic improvement of patients with IBS
Timeline
- Start
- 2021-03-01
- Primary completion
- 2021-10-31
- Completion
- 2021-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Saccharomyces cerevisiae | Other / unclassified | 500 mg | — |